She received only 1 intravitreal anti-vascular endothelial growth factor (VEGF) therapy in OU, however, no improvement in visual acuity or macular edema in OCT (Fig. 4G,H) was observed within 1 month following treatment. This evidence concerns the gene VEGFA and macular retinal edema.